The effects of DEX on the levels of osteoblast differentiation markers, including ALP, OPG, β-catenin, and RANKL was reversed, indicating that CCG may be a suitable compound for the treatment of osteoporosis (Zhu et al., 2015). Here, TNFSF11 is linked to osteoporosis.